Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYSCHEM (I). vs SHUKRA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SYSCHEM (I). SHUKRA PHARMA SYSCHEM (I)./
SHUKRA PHARMA
 
P/E (TTM) x 70.2 19.3 363.7% View Chart
P/BV x 10.7 14.1 76.0% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 SYSCHEM (I).   SHUKRA PHARMA
EQUITY SHARE DATA
    SYSCHEM (I).
Mar-23
SHUKRA PHARMA
Mar-23
SYSCHEM (I)./
SHUKRA PHARMA
5-Yr Chart
Click to enlarge
High Rs6589 73.4%   
Low Rs1111 100.8%   
Sales per share (Unadj.) Rs30.353.7 56.5%  
Earnings per share (Unadj.) Rs1.44.0 35.2%  
Cash flow per share (Unadj.) Rs2.35.7 39.7%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %01.0 0.0%  
Book value per share (Unadj.) Rs7.023.1 30.3%  
Shares outstanding (eoy) m31.8910.96 291.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.9 135.3%   
Avg P/E ratio x27.012.4 217.2%  
P/CF ratio (eoy) x16.98.8 192.5%  
Price / Book Value ratio x5.52.2 252.3%  
Dividend payout %012.4 0.0%   
Avg Mkt Cap Rs m1,217547 222.4%   
No. of employees `000NANA-   
Total wages/salary Rs m4444 99.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m967588 164.4%  
Other income Rs m212 20.7%   
Total revenues Rs m970600 161.6%   
Gross profit Rs m8654 161.2%  
Depreciation Rs m2718 147.1%   
Interest Rs m03 14.9%   
Profit before tax Rs m6244 138.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m160 4,680.0%   
Profit after tax Rs m4544 102.4%  
Gross profit margin %8.99.1 98.1%  
Effective tax rate %26.60.8 3,359.7%   
Net profit margin %4.77.5 62.3%  
BALANCE SHEET DATA
Current assets Rs m586531 110.4%   
Current liabilities Rs m430425 101.1%   
Net working cap to sales %16.118.0 89.7%  
Current ratio x1.41.2 109.1%  
Inventory Days Days40-  
Debtors Days Days1,5821,873 84.5%  
Net fixed assets Rs m319219 145.5%   
Share capital Rs m31939 814.8%   
"Free" reserves Rs m-96214 -44.8%   
Net worth Rs m223253 88.2%   
Long term debt Rs m1638 42.6%   
Total assets Rs m904750 120.6%  
Interest coverage x147.516.8 877.3%   
Debt to equity ratio x0.10.1 48.3%  
Sales to assets ratio x1.10.8 136.3%   
Return on assets %5.06.3 80.6%  
Return on equity %20.217.4 116.2%  
Return on capital %25.916.2 159.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-8532 -268.0%  
From Investments Rs m91-44 -205.1%  
From Financial Activity Rs mNA49 -0.9%  
Net Cashflow Rs m537 14.8%  

Share Holding

Indian Promoters % 53.9 51.0 105.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.1 127.3%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 46.1 49.0 94.0%  
Shareholders   12,571 10,963 114.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SYSCHEM (I). With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SYSCHEM (I). vs RELISH PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SYSCHEM (I). vs RELISH PHARMA Share Price Performance

Period SYSCHEM (I). RELISH PHARMA
1-Day 5.00% -2.00%
1-Month 6.34% 18.32%
1-Year 27.07% 528.10%
3-Year CAGR 98.60% 229.50%
5-Year CAGR 46.25% 114.18%

* Compound Annual Growth Rate

Here are more details on the SYSCHEM (I). share price and the RELISH PHARMA share price.

Moving on to shareholding structures...

The promoters of SYSCHEM (I). hold a 53.9% stake in the company. In case of RELISH PHARMA the stake stands at 51.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SYSCHEM (I). and the shareholding pattern of RELISH PHARMA.

Finally, a word on dividends...

In the most recent financial year, SYSCHEM (I). paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

RELISH PHARMA paid Rs 0.5, and its dividend payout ratio stood at 12.4%.

You may visit here to review the dividend history of SYSCHEM (I)., and the dividend history of RELISH PHARMA.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.